Proceedings of the National Academy of Sciences · 2002 · 358 citations · 23 references
Life SciencesGeneticsMolecular GeneticsHuman GeneticsMedical GeneticsSubstance Use DisordersAddictionAddiction NeurobiologyEnzyme Gene VariantsGenetic Vulnerability To AddictionMissense MutationsProteolytic InactivationSingle-nucleotide Polymorphism VariationSubstance Use Disorder GeneticsSubstance Use GeneticsSubstance Use Vulnerability
Problem drug use and dependence are neurobehavioral disorders of complex origin, with genetic factors contributing 40–60 % of risk, yet the specific genes involved remain largely unknown. The study reports a naturally occurring FAAH missense mutation (Pro129→Thr) that, in homozygous form, is strongly linked to street drug use and problem drug/alcohol use. The mutation converts a conserved proline to threonine, producing a FAAH variant with normal catalytic activity but heightened proteolytic degradation. These findings indicate that FAAH mutations are significant risk factors for drug abuse, linking endogenous cannabinoid system dysfunction to dependence.
Problem drug use and dependence are neurobehavioral disorders of complex origin. Although environmental factors contribute to drug abuse and addiction, genetic factors also play a significant role estimated at 40–60% of the total risk. Nonetheless, the precise identities of human genes that confer vulnerability to problem drug use remain mostly unknown. Here, we describe a natural single nucleotide polymorphism in the human gene that encodes the principal endocannabinoid-inactivating enzyme, fatty acid amide hydrolase (FAAH), that in homozygous form is strongly associated with both street drug use and problem drug/alcohol use. This single nucleotide polymorphism results in a missense mutation (385C→A) that converts a conserved proline residue to threonine (Pro129→Thr), producing a FAAH variant that displays normal catalytic properties but an enhanced sensitivity to proteolytic degradation. Collectively, these results suggest that genetic mutations in FAAH may constitute important risk factors for problem drug use and support a potential link between functional abnormalities in the endogenous cannabinoid system and drug abuse and dependence.
23
The metabolic and molecular bases of inherited disease
Ying-Tsong Chen · Medical Entomology and Zoology · 2001 · 6.9K citations
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
Benjamin F. Cravatt, Dan K. Giang, Stephen P. Mayfield et al. · Nature · 1996 · 2.1K citations
Benjamin F. Cravatt, Kristin Demarest, Matthew P. Patricelli et al. · Proceedings of the National Academy of Sciences · 2001 · 1.3K citations · Full text
Medicine, Neuroscience, Pharmacology +13